Emerging hypotheses suggest that CD10 may influence tumor aggressiveness through its role in extracellular matrix degradation and the modulation of intracellular signaling pathways, as noted by researchers such Biasoli et al. (2005), Kim et al. (2010), Khanh do et al. (2011). The gene discussed is MME; the disease is neoplasm.